Introduction
The retrovirus human T-cell leukemia virus type I (HTLV-I) (reviewed in Johnson et al., 2001 ) is associated with two fatal human diseases, adult T-cell leukemia (ATL) (reviewed in Uchiyama, 1997; Bazarbachi and Hermine, 2001 ), a clonal malignancy of infected mature CD4 þ helper T cells (Poiesz et al., 1980; Yoshida et al., 1982; Yamada, 1983; Kikuchi et al., 1986) , and tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM), a neurodegenerative disease (Gessain et al., 1985) . Infection with HTLV-I is endemic in parts of Japan, South America, Africa, and the Caribbean (Hinuma et al., 1981 Blattner et al., 1982; Saxinger et al., 1984; Slattery et al., 1999) . HTLV-I carriers do not develop disease until 20-30 years after infection, and the cumulative lifetime risk of a carrier developing ATL is approximately 4% (Murphy et al., 1989) . The long clinical latency and the low percentage of individuals who develop leukemia suggest that T-cell transformation occurs after a series of cellular alterations and/or mutations. Although the HTLV-I genome also encodes several other proteins that appear to contribute to infection and oncogenesis (reviewed in Albrecht and Lairmore, 2002) , the viral transcriptional transactivator protein, Tax, is thought to be the major viral oncoprotein (Grassmann et al., 1992) and this review focuses specifically on Tax and its effects on cellular functions including cell-cycle progression and DNA damage repair.
Transformation by HTLV-I
A number of studies have demonstrated that Tax is the major transforming protein of HTLV-I, although the basis of cellular transformation by Tax is not fully understood Grassmann et al., 1989 Grassmann et al., , 1992 Pozzati et al., 1990; Tanaka et al., 1990; Smith and Greene, 1991; Yamaoka et al., 1992; Herdegen and Leah, 1998) . Transforming retroviruses typically either encode oncogenes that mediate viral transformation, or they disrupt cellular gene expression as a byproduct of proviral integration (Bruge and Erickson, 1977; Paul et al., 1989) . Neither of these classic models explains HTLV-I transformation since proviral integration is random and since no cellular homologue of Tax has been identified. Although no common integration site is found among patients, integration of the proviral genome into host cell DNA is monoclonal in transformed cells from a given individual, suggesting that integration occurs prior to transformation and that transformation is a rare event among infected cells.
Numerous studies have established that Tax expression is both necessary and sufficient to establish and maintain the transformed phenotype. When the 3 0 portion of the HTLV-I genome (containing the tax gene) was delivered in a transformation-defective Herpesvirus saimiri vector, it was able to transform T cells, resulting in clonal cell lines of the same phenotype as HTLV-I transformed T cells (Grassmann et al., 1989) . Of the three proteins encoded in the 3 0 portion of the genome, Tax was required for transformation since specific mutation of the Tax initiation codon eliminated the transforming potential of the H. saimiri recombinant virus (Grassmann et al., 1992) . Additionally, a defective HTLV-I provirus cloned from leukemic cells of an ATL patient was able to transform NIH 3T3 and Rat1 cells (Tanaka et al., 1990) , and mutational analysis confirmed that Tax was necessary for transformation and tumorigenesis induced by HTLV-I. Experiments designed to address whether Tax is sufficient for transformation originally showed that Tax in combination with ras could transform primary rat embryo fibroblasts in vitro (Pozzati et al., 1990) , and subsequently that Tax alone could transform Rat2 cells (Smith and Greene, 1991) . The first generation of transgenic mice expressed Tax under control of the HTLV-I LTR and displayed neurofibromas and mesenchymal tumors Nerenberg et al., 1987) . Although a number of subsequent studies have reported the development of tumors in Tax transgenic mice dependent on the tissue targeted for expression, one of the most encouraging models is transgenic mice expressing Tax under control of the human granzyme B promoter, which directs expression specifically to T cells (Grossman et al., 1995) . At 6-9 months of age these animals develop primary, peripheral lymphomas consisting predominately of CD8 þ T and NK cells. Based on these combined studies, Tax is considered a viral oncogene without an identified cellular homologue.
Although Tax lacks a cellular homologue (Seiki et al., 1984) , it functions like an oncogene, inducing leukemogenesis by causing aberrant transactivation of cellular growth regulatory genes. A large group of cellular genes involved in T-cell growth are activated by Tax including interleukin 2 (IL-2), the high-affinity subunit of the IL-2 receptor (IL-2Ra), IL-3, IL-4, granulocyte-macrophage colony-stimulating factor, proliferating cell nuclear antigen (PCNA), transforming growth factor beta (TGF-b), vimentin, proenkephalin, egr-1 (Krox20), egr-2 (Krox24), fra-1, c-fos, c-myc, c-sis, bcl-xL, c-Jun, JunB, and JunD (reviewed in ). Tax has also been shown to repress expression of b-polymerase (an enzyme involved in DNA repair), lck, and bax Brauweiler et al., 1997; Lemasson et al., 1997) . Tax-driven transcriptional activation of gene expression is mediated through the CREB, NF-kB, and SRF pathways (Yoshida, 2001) . Owing to its role in viral transformation, the mechanisms by which Tax modulates viral and host cell transcription are of considerable interest. These transcriptional pathways will not be discussed because of spatial constraints. Instead we direct the reader to Yoshida (2001) for an excellent review of this topic.
Transformed cells isolated from ATL patients do not express viral proteins and whether continued expression of Tax is required for transformation remains controversial. In one study, morphologic revertants of HTLV-I-transformed Rat1 cells were selected and found to have lost the tax gene (Yamaoka et al., 1992) . Reintroduction of the tax gene into these cells restored the transformed phenotype suggesting that Tax is required both to establish and maintain the transformed phenotype. In contrast, treatment of transformed fibroblast cell lines derived from Tax transgenic mice with Tax antisense oligonucleotides caused a 90% reduction in Tax expression, but had no effect on the cell growth rate or their ability to form tumors in vivo (Kitajima et al., 1992) suggesting that Tax expression is not required to maintain the transformed phenotype. This latter result is supported by patient studies, in which very sensitive assays such as RT-PCR are required in order to detect viral gene products . Even when detected in leukemic cells, Tax expression is low and occurs in only a small percent of infected cells (Kinoshita et al., 1989) . In contrast, Tax expression is relatively easily detected in infected peripheral blood mononuclear cells of seropositive carriers . These results suggest that Tax may initiate a cascade of events leading toward transformation that, at later stages, may not require expression of Tax itself.
Cell-cycle dysregulation
T-lymphocyte proliferation is highly regulated, but HTLV-I Tax has developed numerous mechanisms to subvert this control and induce T-cell proliferation in the absence of appropriate signals. For example, high levels of IL-2 are required to promote the progression of resting T cells through the cell cycle. Upon binding to its receptor (IL-2R), IL-2 triggers production of itself as well as IL-2Ra, an additional subunit of the IL-2 receptor that increases the affinity of the receptor for IL-2. Cells expressing the high-affinity IL-2R are more sensitive to IL-2 and continue to proliferate (reviewed in Hollsberg, 1999) . Early in HTLV-I infection, most infected T cells require IL-2 to proliferate; however, later in infection, their proliferation becomes IL-2 independent (Yssel et al., 1989) . Tax has several effects on the IL-2 pathway that may explain this observation. Tax has been shown to transactivate both the IL-2 and IL-2Ra promoters through an NF-kB-like DNA element, leading to increased secretion of IL-2 and expression of the high-affinity IL-2R on the surface of infected cells (Inoue et al., 1986; Cross et al., 1987; Maruyama et al., 1987; Siekevitz et al., 1987; Ballard et al., 1988; Ruben et al., 1988; Leung and Nabel, 1988) . Moreover, IL-2-independent HTLV-I-infected T cells have a constitutively activated JAK-STAT pathway, which is involved in IL-2R signal transduction. As a result, these cells no longer require IL-2 to activate the pathway and proliferate. Conclusively, HTLV-Iinfected T cells that still require IL-2 to proliferate do not have a constitutively activated JAK-STAT pathway (Migone et al., 1995; Xu et al., 1995; Takemoto et al., 1997) .
In addition to activating T-cell proliferation, Tax can also inhibit the activity of growth suppressors such as TGF-b. ATL cells secrete an increased amount of TGFb because of Tax transactivation of the TGF-b promoter (Niitsu et al., 1988; Kim et al., 1990) ; however, the cells are resistant to growth inhibition by TGF-b (Hollsberg et al., 1994) . This resistance is because of numerous effects of Tax on the TGF-b pathway. First, Tax represses the TGF-b signaling pathway by binding and sequestering the transcription factor CBP/p300, leaving it unavailable to interact with and activate Smad proteins to transcribe TGF-b-responsive genes (Mori et al., 2001; Lee et al., 2002) . Second, Tax interacts directly with some of the Smad proteins, preventing their interaction with CBP/p300 (Lee et al., 2002) . Finally, Tax interferes with the function of some TGFb-responsive proteins, such as p15 INK4b , by binding to the protein and inhibiting its ability to induce cell-cycle arrest Suzuki et al., 1999a) . So, although Tax enhances TGF-b production, infected cells are resistant to TGF-b growth inhibition because Tax disrupts the TGF-b signaling pathway and interferes with the function of growth inhibiting proteins induced by TGF-b.
An additional disruptive effect of Tax emanates from its impact on the ability of the cell-cycle machinery to regulate DNA replication and cell division (reviewed in Mesnard and Devaux, 1999; Jeang, 2000, 2002; Yoshida, 2001; Hatta and Koeffler, 2002) . Progression through various stages of the cell cycle is controlled by different cyclin/cdk (cyclin-dependent kinase) complexes. Since Cdk levels are relatively constant throughout the cell cycle, their activity is regulated by cyclins whose levels fluctuate during the cell cycle (reviewed in Hunter and Pines, 1994; Ortega et al., 2002) . During G 1 phase of the cell cycle, the cell passes a restriction point after which it is committed to enter S phase and replicate DNA. Progression through G 1 and the G 1 /S phase transition is controlled by multiple levels of regulation to ensure that DNA replication only occurs under favorable conditions (reviewed by Bartek and Lukas, 2001a,b) . The effects of Tax on G 1 progression and the G 1 /S transition have been extensively studied. In general, Tax shortens the length of G 1 and accelerates entry into S phase Liang et al., 2002) .
Progression through G 1 is determined in part by the availability of the E2F transcription factor, which activates a variety of genes required for S phase. E2F activity is suppressed when it is bound by hypophosphorylated retinoblastoma (Rb) protein. During G 1 , cyclin E/cdk2 or cyclin D/cdk4 or 6 hyperphosphorylates Rb causing it to dissociate from E2F. Active unbound E2F then transcribes genes needed for S phase (reviewed in Adams, 2001) . In ATL cells, unlike in many other cancers, the Rb gene is usually not mutated (Hatta et al., 1997) ; rather Tax affects other aspects of the Rb and E2F interaction. In Tax-expressing cells and ATL cells in culture, Tax stimulates cyclin/cdk activity, resulting in hyperphosphorylated Rb (discussed later). Tax also increases E2F transcription and protein levels (Lemasson et al., 1998; Neuveut et al., 1998; Nakayama et al., 2000; Ohtani et al., 2000; Iwanaga et al., 2001) . The cumulative effect of hyperphosphorylated Rb and increased E2F transcription is the availability of more active E2F, which facilitates the entry of Tax-expressing cells into S phase.
Tax also increases the levels and activity of several cyclin/cdk partners, which are important in G 1 progression and S phase entry. Tax transactivates genes encoding G 1 cyclins D1, D2, and D3 and increases the kinase activity of cdk2, 4, and 6, which phosphorylate Rb and regulate G 1 progression and the G 1 /S transition (Figure 1) (Akagi et al., 1996; Neuveut et al., 1998; Schmitt et al., 1998; Santiago et al., 1999; Haller et al., 2000; Huang et al., 2001; Iwanaga et al., 2001; Haller et al., 2002; Mori et al., 2002) . Tax also interacts with cdk4 and cdk6 and enhances cdk4 binding to cyclin D2 resulting in an earlier onset of cdk kinase activity and an earlier accumulation of hyperphosphorylated Rb in Tax-expressing cells than in cells not expressing Tax (Haller et al., 2002) . The resultant earlier release of E2F likely drives the earlier S phase entry observed in Taxexpressing cells. Figure 1 Regulation of G1 phase progression by Tax. Cyclins D and E regulate progression through G1 and S phase entry by binding to cdks 2, 4, and 6. The major substrate for the cyclin D/cdk complexes is the retinoblastoma (Rb) protein. The active cycD/cdk complex regulates cell-cycle progression from G1 into S phase by phosphorylating Rb, resulting in release of the E2F transcription factor which can then activate expression of S phase genes. Tax has been shown to activate the expression of cyclin D, cdk4, cdk6, and cdk2, which could stimulate the cell-cycle-promoting activities of these complexes. Tax has also been shown to repress the expression of, or inhibit the function of, nearly all cdk inhibitors (p27 Kip1 , p15  INK4b , p16  INK4a , p18   INK4c , p19 INK4d ) with the notable exception of p21 waf1 , which is activated by Tax. The general repression of cdk inhibitors by Tax promotes cell-cycle progression by allowing constitutive activation of cyclin/cdk complexes Cellular transfrormations by the HTLV-I Tax Protein ML Gatza et al A central tenet of cell-cycle control is that distinct checkpoints regulate progression through critical points in cell cycle (such as the G 1 /S transition, G 2 /M transition, and mitosis). These checkpoints are regulated by numerous signaling pathways and cdk inhibitors (reviewed in Bartek and Lukas, 2001a, b) . Checkpoints can be triggered by DNA damage or other circumstances detrimental to the cell. Tax disrupts the DNA damage-induced G 1 /S checkpoint (controlled by cyclin E/cdk 2), in part by inactivation of p53 (discussed later). Normally when DNA damage is detected during G 1 , p53 activates the cdk inhibitor p21 waf1 , which in turn binds and inactivates cdk2. Although p53 is inactivated, Tax-expressing cells have higher levels of p21 waf1 because Tax transactivates the p21 waf1 promoter (Akagi et al., 1996; Cereseto et al., 1996; De La Fuente et al., 2000; Iwanaga et al., 2001) . However, p21 waf1 expression is not further induced after DNA damage, and the protein does not appear to be functional in the G 1 /S checkpoint (Lemoine and Marriott, unpublished data) . Inactivation of the G 1 /S checkpoint could lead to S phase entry in the presence of unrepaired DNA damage, and cause an increased frequency of permanent mutations.
Tax also disrupts the function of other cdk inhibitors. The cdk inhibitor p16
INK4a interacts with cdk4 preventing it from forming an active complex with cyclin D1.
Tax binds p16

INK4a
, precluding its sequestration of cdk4 and thereby promoting formation of the active cdk4/ cyclin D1 complex (Suzuki et al., 1996; Low et al., 1997) .
Whether the inactivation of p16
INK4a is critical in Tax transformation is unclear because in p16
INK4a null cells Tax still increases cdk4 activity (Neuveut et al., 1998) , and because p16
INK4a is often deleted in ATL cells (Hatta et al., 1995) . Tax also decreases the levels of the cdk inhibitors, p15
INK4b , p18 INK4c , p19 INK4d , and p27
Kipl (Akagi et al., 1996; Cereseto et al., 1999; Iwanaga et al., 2001) . These various activities of Tax converge to subvert many cell-cycle controls suggesting that Taxcontaining cells may be more prone to acquire mutations that could eventually lead to cellular transformation and ATL.
Repression of p53
The tumor suppressor p53 plays a pivotal role in guarding the cell against transformation. In response to various cellular stresses, including DNA damage and oncogene activation, p53 mediates growth arrest or apoptosis through transcriptional activation of cell-cycle control proteins (Gottlieb and Oren, 1996 ; Ko and Prives, 1996; Giaccia and Kastan, 1998; Meek, 1999). Although it has been demonstrated that Tax expression results in a minor effect on the transactivation of p21 waf1 , transactivation of PCNA, by Tax, allows the cell to overcome the p21 waf1 block in DNA replication. These events result in the fixation of DNA lesions as mutations in the genome Cellular transfrormations by the HTLV-I Tax Protein ML Gatza et al p53 is one of the most frequently mutated genes in human cancers with approximately 60% of all tumors, albeit only 30% of ATL cases, demonstrating a defect in this gene (Cesarman et al., 1992; Sakashita et al., 1992; Levine, 1997) . In virally transformed cells, p53 is a major target for inactivation, as many viral oncogenes (e.g. SV40 large T-Ag, hepatitis B X protein, adenovirus E4 orf6, cytomegalovirus IE2, and the human papillomavirus E6 and E7 proteins) interfere with p53 function (Prives and Manfredi, 1993; Demers et al., 1994 Demers et al., , 1996 Truant et al., 1995; Dobner et al., 1996; Tsai et al., 1996) . Loss of p53 function prevents proper G 1 /S arrest, p53-mediated apoptosis, and DNA repair, all of which contribute to cellular transformation.
A series of studies have demonstrated that in HTLV-I-infected cells, Tax has the ability to abrogate the transactivating function of p53 (Figure 2) . Interestingly, whereas p53 mRNA levels remain unaffected in these cells, p53 protein levels are elevated, implying that Tax represses p53 function by increasing protein stability and/or through post-translational modifications (Reid et al., 1993; Yamato et al., 1993; Gartenhaus and Wang, 1995; Akagi et al., 1997) .
There are conflicting opinions on the mechanism by which Tax mediates the loss of p53 function in vivo. Although Tax does not bind p53, alter its subcellular localization, or disrupt its DNA-binding activity (Uittenbogaard et al., 1995; Mulloy et al., 1998; PiseMasison et al., 1998) , data do support two mechanisms of Tax-mediated suppression of p53 function: inactivation through differential phosphorylation of p53, and competitive binding of CBP/p300 by Tax. The aminoterminal transactivation domain of p53 interacts with a variety of transcription factors, including TFIID, TFIIH, and CBP/p300 in order to regulate p53-mediated transcription of cell-cycle control genes (Xiao et al., 1994; Lu and Levine, 1995; Thut et al., 1995; Leveillard et al., 1996; Gu et al., 1997; Lill et al., 1997) . If Tax outcompetes p53 for CBP/p300 binding, p53-mediated transactivation of cellular genes is inhibited (Van Orden et al., 1999a, b; Suzuki et al., 1999b; Ariumi et al., 2000) . Recently, Tax binding to CBP/p300 was shown to be necessary, but not sufficient to repress activity; p53 phosphorylation at serine 15 and 293 is also required (Pise-Masison et al., 1998; Van et al., 2001 ). These results have fueled an ongoing debate over the mechanisms and pathways involved in Tax-mediated suppression of p53 function and many more studies will be required to fully resolve this issue.
Repression of DNA repair
Both HTLV-I-transformed lymphocytes isolated from patients and those immortalized in culture demonstrate a wide range of chromosomal abnormalities that include deletions, translocations, rearrangements, duplications, and euploidy (Miyamoto et al., 1983; Rowley et al., 1984 ; Whang-Peng et al., 1985; Chieco-Bianchi et al.,
1988; Itoyama et al., 1990; Maruyama et al., 1990; Tanaka et al., 1990; Sadamori, 1991; Kamada et al., 1992; Fujimoto et al., 1999) . Currently, there is no evidence linking a specific type of chromosomal damage to the development of ATL. Tax has the ability to affect a wide range of cellular functions through transcriptional activation of cellular genes, protein-protein interactions and post-translational modification of cellular proteins but there is no evidence that Tax directly induces DNA damage (Majone and Jeang, 2000) . Rather, Tax appears to inhibit the cell's ability to repair DNA damage introduced from exogenous sources, resulting in an increased mutation frequency within cells (Miyake et al., 1999) . Whether induced by environmental factors or as a result of the misincorporation of bases during replication, cellular DNA damage is repaired by several functionally overlapping pathways, including nucleotide excision repair (NER), base excision repair (BER), mismatch repair (MMR), and recombination repair. Suppression of some or all of these pathways by HTLV-I Tax would likely increase the incidence of genomic mutations and contribute to Tax-mediated cellular transformation. Jeang et al. (1990) determined that Tax transrepresses the promoter of DNA polymerase b, an enzyme involved in both BER and MMR (Figure 2 ). Micronuclei formation assays provided further evidence that Tax suppresses DNA repair (Majone et al., 1993) . Micronuclei form as a result of chromosomal damage (Parry and Parry, 1987) and following mitosis, exist in the cytoplasm, separate from the rest of the nucleus (Thompson and Perry, 1988) . Cells transiently transfected with a Tax expression plasmid display a significant increase in micronuclei formation (Majone et al., 1993) . Tax-expressing cells have also been shown to be more susceptible to DNA damage by mitomycin C than non-Tax-expressing cells (Saggioro et al., 1994) . Together, these observations suggest that Tax expression might repress certain DNA repair mechanisms.
NER was the first DNA repair pathway specifically shown to be suppressed by Tax (Kao and Marriott, 1999) . Possibly the most versatile repair system present in cells, NER components survey the genome for helix distortions caused by damage (global genomic NER) and recognize stalled RNA polymerase complexes blocked by damage (transcription-coupled NER) (de Laat et al., 1999) . In the presence of DNA damage, elevated levels of the cyclin-dependent kinase, p21 waf1 interact with PCNA, resulting in repression of PCNAdependent replication without disrupting PCNA-dependent repair (Saggioro et al., 1994; Waga et al., 1994) . It has been demonstrated that excess PCNA allows cells to overcome the p21 waf1 -mediated block in replication by enabling DNA polymerase d to synthesize through template lesions (Li et al., 1994) . Interestingly, Tax has been shown to activate the PCNA promoter and induce cellular overexpression of PCNA (Ressler et al., 1997) . The ability of Tax to stimulate PCNA expression correlates directly with its ability to repress NER (Lemoine et al., 2000) . Several groups have demonstrated that p53 is required for efficient global genome NER, but not for transcription-coupled NER Hanawalt, 1995, 1997; Smith et al., 1995; Wang et al., 1995) . As previously discussed, Tax inhibits the transactivating function of p53. Rescue of Tax-mediated suppression of NER by wild-type p53 suggests that global genome NER is inhibited by Tax. There are currently no data to suggest that Tax affects transcription-coupled NER. Together, inhibition of NER-and PCNA-mediated bypass of the p21 waf1 -dependent block in replication provide a mechanism by which Tax allows the cell to replicate DNA through damage, leading to an increased rate of nucleotide misincorporation.
Shortly after NER was shown to be affected by Tax, Philpott and Buehring (1999) demonstrated that BER is also inhibited by Tax. BER (Nilsen and Krokan, 2001 ) removes a wide range of genomic lesions including, but not limited to, spontaneous hydrolytic depurination of DNA, deamination of cytosine and 5-methylcytosine, products of reactions with hydroxyl-free radicals, and covalent DNA adducts (Wood and Shivji, 1997) . BER can be divided into two distinct pathways: short-patch repair (major pathway) removes individual damaged nucleotides, whereas long-patch repair (minor pathway) resolves DNA segments two to 10 nucleotides in length. Since Tax mediates the transrepression of DNA polymerase b , which is required for single-nucleotide gap filling reactions, Tax likely represses the major, short-patch pathway of BER. It remains to be determined whether the long-patch BER pathway, which is mediated by a combination of DNA polymerases b and d/e together with PCNA, is affected by Tax. It is conceivable that a p53-dependent mechanism similar to that previously described for NER may be involved in Tax-mediated repression of BER. A recent study has demonstrated that p53 plays an indispensable role in BER by directly interacting with both the AP endonuclease and DNA polymerase b (Zhou et al., 2001) . However, very little is known about Tax-mediated repression of BER, and the effects of Tax may occur at other stages of the repair pathway (e.g. glycoslase-mediated recognition of template lesions, strand excision by the exonuclease, and/or transactivation of other BER core components). Elucidating mechanisms of Tax-mediated repression of both NER and BER are important areas for future research.
Currently, there is no published evidence linking Tax to repression of either recombinational repair or MMR. Furthermore, preliminary studies on the effects of Tax on recombinational repair have demonstrated no discernable difference in either nonhomologous end joining or homologous recombination-mediated repair in the presence of Tax (Gatza, Lemoine, and Marriott, unpublished observations). These interactions, however, have not been exhaustively studied, and given the redundancy of DNA repair pathways, additional studies will be required to specifically rule out a Tax-mediated effect on these particular repair mechanisms.
Effects of Tax on aneuploidy
Despite the fact that nearly 70% of all cancers demonstrate aneuploidy (including both ATLand HTLV-I-infected cells), only rarely have genetic defects been identified in mitotic checkpoint genes, implying that other events must alter function of the mitotic spindle checkpoint (MSC) (Shimoyama, 1991; Cahill et al., 1998; Tighe et al., 2001) . The MSC, responsible for regulating the onset of anaphase and the cell's subsequent commitment to divide, is regulated by at least seven known proteins including: mitotic arrest-defective (MAD) -1, -2, -3 (Li and Murray, 1991) ; budding uninhibited by benzimidazole (BUB) -1, -2, -3 (Hoyt et al., 1991) ; and monopolar spindle 1 (MPS1) (Godden-Kent et al., 1997; Abrieu et al., 2001) . Recent studies have reported that perturbation of the MSC correlates with the development of aneuploidy. Several years ago, HTLV-I Tax was shown to bind and inactivate hsMAD-1 (Jin et al., 1998) . This finding was recently extended when it was demonstrated that nearly all HTLV-I-transformed cells are defective in the MSC (Kasai et al., 2002) . In addition to sequestering of hsMAD1 by Tax, both hsMAD1 and -2 were mislocalized from the nucleus to the cytoplasm (Kasai et al., 2002) , an intriguing observation considering that hsMAD1 is required to direct hsMAD2 to kinetochores (Chen et al., 1998) . Loss of hsMAD1 function therefore prevents proper localization of hsMAD2, resulting in a defective MSC. As with Tax-mediated abrogation of various DNA repair pathways, very few studies have been published investigating mechanism(s) by which Tax affects the MSC. Research on both DNA repair and MSC are vital to understanding HTLV-I-mediated cellular transformation and are a high priority for future studies.
Conclusions
That chromosomal aberrations and genomic instability play a major role in the development and progression of multistep tumors has been well documented (Klein and Klein, 1985; Bishop, 1999) . In fact, statistical analysis suggests that five independent genetic events are probably required to develop ATL following viral infection of the target T cells (Okamoto et al., 1989) . As we have previously discussed, Tax-expressing cells demonstrate an increased cellular mutation frequency, achieved by suppressing DNA repair and enhancing DNA replication and cell-cycle progression. The multitude of Tax functions described in this review provide the basis for HTLV-I-mediated cellular transformation, in which the suppression of DNA repair pathways and the dysregulation of the cell cycle leads to the gradual accumulation of mutations over time and in rare instances to the development of ATL.
